Pinhas-Hamiel Orit, Zalel Yaron, Smith Eric, Mazkereth Ram, Aviram Ayala, Lipitz Shlomo, Achiron Reuven
Pediatric Endocrinology and Neonatology Unit, Sheba Medical Center, Ramat-Gan 52621, Israel.
J Clin Endocrinol Metab. 2002 Oct;87(10):4547-53. doi: 10.1210/jc.2001-011034.
We describe our experience with prenatal diagnosis of sex differentiation disorders, with focus on the role of ultrasound scans for coherent assessment of prenatal diagnosis. Over a 5-yr period all cases suspected of sexual ambiguity based on abnormal ultrasonographic scans (US) or US/genotype US discrepancy were evaluated prenatally by three modalities: 1) repeated fetal US; 2) genetic studies, primarily karyotype and fluorescence in situ hybridization analysis of sex-determining region on the Y gene (SRY); and 3) hormonal assays of amniotic fluid. Of approximately 10,000 gestations, 16 fetuses underwent prenatal evaluation. Twelve were referred because of an abnormal US and 4 because of genotype-phenotype discrepancy. Five fetuses were diagnosed with female pseudohermaphroditism (21-hydroxylase deficiency in 3 and urorectal septum malformation sequence in 2). Four fetuses were diagnosed with male pseudohermaphroditism (1 with steroid sulfatase deficiency, 1 with presumed camptomelic dysplasia, and 2 undetermined). Five cases had chromosomal abnormalities, and 2 had 46,XX+SRY sex reversal. In all genetic females the uterus was observed on US. In 11 cases initial US scan was performed at 13-15 wk; in 7 of 11, although the initial scan was normal, a repeated scan later in gestation revealed an abnormality. Repeated US scans performed at 13-15 and 22-24 wk gestation are a helpful tool in prenatal diagnosis of sex differentiation disorders. Our data suggest that both size and structure anomalies of the reproductive structures may evolve throughout pregnancy, and that they represent a developmental biological process rather than a single nonprogressive pathological event. US scan after approximately 19 wk enables detection of the uterus and provides pivotal information in cases of ambiguity. If the uterus appears normal, the most likely diagnosis is a virilized karyotypic female. Prenatal diagnosis allows for early parental counseling and anticipation of medical management postnatally.
我们描述了产前诊断性别分化障碍的经验,重点关注超声扫描在连贯评估产前诊断中的作用。在5年期间,对所有基于异常超声扫描(US)或US/基因型US差异而疑似性器官模糊的病例进行了三种方式的产前评估:1)重复胎儿超声检查;2)遗传学研究,主要是核型分析和Y基因性别决定区域(SRY)的荧光原位杂交分析;3)羊水激素测定。在大约10,000次妊娠中,有16例胎儿接受了产前评估。12例因超声异常转诊,4例因基因型-表型差异转诊。5例胎儿被诊断为女性假两性畸形(3例为21-羟化酶缺乏,2例为尿直肠隔畸形序列)。4例胎儿被诊断为男性假两性畸形(1例为类固醇硫酸酯酶缺乏,1例推测为弯曲侏儒症,2例未明确)。5例有染色体异常,2例有46,XX+SRY性反转。在所有遗传女性中,超声检查均观察到子宫。11例在孕13-15周进行了首次超声扫描;其中7例虽然首次扫描正常,但妊娠后期重复扫描发现异常。在孕13-15周和22-24周进行的重复超声扫描是产前诊断性别分化障碍的有用工具。我们的数据表明,生殖结构的大小和结构异常在整个孕期可能会演变,它们代表的是一个发育生物学过程,而非单一的非进行性病理事件。孕19周左右后的超声扫描能够检测到子宫,并在诊断不明确的病例中提供关键信息。如果子宫看起来正常,最可能的诊断是核型为女性但有男性化表现。产前诊断有助于早期为父母提供咨询,并为产后医疗管理做好准备。